264 related articles for article (PubMed ID: 35372405)
1. Clinical Overview of Progressive Fibrotic Interstitial Lung Disease.
Case AH
Front Med (Lausanne); 2022; 9():858339. PubMed ID: 35372405
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and Management of Fibrotic Interstitial Lung Diseases.
Collins BF; Luppi F
Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
4. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
5. The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.
Puiu R; Motoc NS; Lucaciu S; Ruta MV; Rajnoveanu RM; Todea DA; Man MA
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540667
[TBL] [Abstract][Full Text] [Related]
6. Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort.
Seixas E; Ferreira M; Serra P; Aguiar R; Cunha I; Ferreira PG
Afr J Thorac Crit Care Med; 2022; 28(4):. PubMed ID: 36817315
[TBL] [Abstract][Full Text] [Related]
7. Progressive fibrotic interstitial lung disease.
Pereira CAC; Cordero S; Resende AC
J Bras Pneumol; 2023; 49(5):e20230098. PubMed ID: 37610955
[TBL] [Abstract][Full Text] [Related]
8. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
9. Advances with pharmacotherapy for the treatment of interstitial lung disease.
Comes A; Sgalla G; Perrotta A; Richeldi L
Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD.
Shumar JN; Chandel A; King CS
J Clin Med; 2021 May; 10(11):. PubMed ID: 34070297
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic and network analysis identifies shared and unique pathways and immune changes across fibrotic interstitial lung diseases.
Liu W; Huang K; Yang XZ; Wang P
Aging (Albany NY); 2024 Feb; 16(4):3200-3230. PubMed ID: 38349858
[TBL] [Abstract][Full Text] [Related]
12. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
[TBL] [Abstract][Full Text] [Related]
13. Progression of fibrosing interstitial lung disease.
Wong AW; Ryerson CJ; Guler SA
Respir Res; 2020 Jan; 21(1):32. PubMed ID: 31996266
[TBL] [Abstract][Full Text] [Related]
14. New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?
Morisset J; Lee JS
Curr Opin Pulm Med; 2019 Sep; 25(5):442-449. PubMed ID: 31365378
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic Therapy: Is There a Role in Myositis-Interstitial Lung Disease?
Soskis A; Hallowell R
Respiration; 2021; 100(9):923-932. PubMed ID: 33951665
[TBL] [Abstract][Full Text] [Related]
16. Real-life prevalence of progressive fibrosing interstitial lung diseases.
Gagliardi M; Berg DV; Heylen CE; Koenig S; Hoton D; Tamirou F; Pieters T; Ghaye B; Froidure A
Sci Rep; 2021 Dec; 11(1):23988. PubMed ID: 34907290
[TBL] [Abstract][Full Text] [Related]
17. Pathological Insight into 5-HT
Löfdahl A; Tornling G; Wigén J; Larsson-Callerfelt AK; Wenglén C; Westergren-Thorsson G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379351
[TBL] [Abstract][Full Text] [Related]
18. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Approach to Adult Fibrotic Lung Diseases.
Adegunsoye A; Strek ME
Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
[TBL] [Abstract][Full Text] [Related]
20. Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Ghazipura M; Mammen MJ; Herman DD; Hon SM; Bissell BD; Macrea M; Kheir F; Khor YH; Knight SL; Raghu G; Wilson KC; Hossain T
Ann Am Thorac Soc; 2022 Jun; 19(6):1040-1049. PubMed ID: 35499854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
